🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/08/2012 | 42,18 | 42,60 | 42,15 | 42,45 | +0,77% | 1,06% | 9.532.608 |
| 03/08/2012 | 42,40 | 42,63 | 42,06 | 42,13 | +0,55% | 1,35% | 10.496.139 |
| 02/08/2012 | 42,02 | 42,20 | 41,53 | 41,90 | -0,84% | 1,61% | 10.318.503 |
| 01/08/2012 | 42,41 | 42,74 | 42,08 | 42,25 | +0,25% | 1,55% | 11.781.092 |
| 31/07/2012 | 42,41 | 42,64 | 42,15 | 42,15 | -0,70% | 1,17% | 13.242.423 |
| 30/07/2012 | 42,60 | 42,87 | 42,30 | 42,44 | -1,37% | 1,34% | 13.571.914 |
| 27/07/2012 | 41,75 | 43,10 | 41,47 | 43,03 | +4,09% | 3,91% | 31.419.983 |
| 26/07/2012 | 41,08 | 41,75 | 41,01 | 41,35 | +1,67% | 1,79% | 17.085.858 |
| 25/07/2012 | 40,94 | 41,02 | 40,42 | 40,67 | -0,16% | 1,47% | 12.818.717 |
| 24/07/2012 | 41,24 | 41,37 | 40,32 | 40,73 | -1,34% | 2,55% | 21.354.886 |
| 23/07/2012 | 41,24 | 41,45 | 41,09 | 41,29 | -0,32% | 0,88% | 15.069.297 |
| 20/07/2012 | 41,62 | 41,66 | 41,33 | 41,42 | -1,21% | 0,80% | 13.641.606 |
| 19/07/2012 | 41,94 | 42,01 | 41,55 | 41,93 | +0,00% | 1,12% | 14.661.625 |
| 18/07/2012 | 41,92 | 42,09 | 41,68 | 41,93 | -0,57% | 0,98% | 16.989.233 |
| 17/07/2012 | 41,31 | 42,34 | 41,18 | 42,17 | +1,94% | 2,80% | 21.110.702 |
| 16/07/2012 | 41,24 | 41,54 | 41,03 | 41,36 | -0,28% | 1,23% | 15.964.603 |
| 13/07/2012 | 41,09 | 41,57 | 40,96 | 41,48 | +1,30% | 1,49% | 17.782.988 |
| 12/07/2012 | 40,91 | 41,20 | 40,80 | 40,94 | +4,13% | 0,98% | 48.160.945 |
| 11/07/2012 | 39,48 | 39,57 | 39,18 | 39,32 | -0,39% | 0,99% | 12.955.586 |
| 10/07/2012 | 40,25 | 40,28 | 39,37 | 39,48 | -1,80% | 2,25% | 17.512.499 |
| 09/07/2012 | 39,80 | 40,32 | 39,63 | 40,20 | +1,49% | 1,75% | 21.190.350 |
| 06/07/2012 | 39,44 | 39,65 | 39,40 | 39,61 | -0,29% | 0,63% | 10.543.509 |
| 05/07/2012 | 39,76 | 39,89 | 39,41 | 39,72 | -0,43% | 1,20% | 9.695.467 |
| 03/07/2012 | 39,82 | 40,04 | 39,66 | 39,90 | -0,10% | 0,96% | 7.912.924 |
| 02/07/2012 | 39,36 | 39,93 | 39,34 | 39,93 | +0,24% | 1,50% | 15.022.137 |
| 29/06/2012 | 39,02 | 39,84 | 39,02 | 39,84 | +2,63% | 2,10% | 24.811.924 |
| 28/06/2012 | 38,56 | 38,84 | 38,35 | 38,82 | +0,37% | 1,26% | 13.165.500 |
| 27/06/2012 | 38,24 | 38,88 | 38,14 | 38,67 | +1,17% | 1,95% | 13.757.620 |
| 26/06/2012 | 38,00 | 38,93 | 37,90 | 38,23 | +0,68% | 2,71% | 11.988.177 |
| 25/06/2012 | 38,08 | 38,21 | 37,88 | 37,97 | -0,97% | 0,85% | 16.084.704 |